106 related articles for article (PubMed ID: 8991709)
1. [The pathophysiological basis of the destabilization of the clinical course in ischemic heart disease].
Babov KD; Shumakov VO; Bratus' VV
Fiziol Zh (1994); 1996; 42(1-2):17-24. PubMed ID: 8991709
[TBL] [Abstract][Full Text] [Related]
2. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
[TBL] [Abstract][Full Text] [Related]
4. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction.
Mathur A; Robinson MS; Cotton J; Martin JF; Erusalimsky JD
Thromb Haemost; 2001 Jun; 85(6):989-94. PubMed ID: 11434707
[TBL] [Abstract][Full Text] [Related]
6. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
7. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.
Al-Nozha MM; Abdel-Gader AG; Arafah MR; Al-Maatouq MA; Al-Shahid MS; Al-Harthi SS; Khan NB; Abdullah MA
Saudi Med J; 2005 Jun; 26(6):937-42. PubMed ID: 15983678
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic neural hyperactivity and its normalization following unstable angina and acute myocardial infarction.
Graham LN; Smith PA; Stoker JB; Mackintosh AF; Mary DA
Clin Sci (Lond); 2004 Jun; 106(6):605-11. PubMed ID: 14759219
[TBL] [Abstract][Full Text] [Related]
10. Immature platelets in patients with acute coronary syndromes.
Grove EL; Hvas AM; Kristensen SD
Thromb Haemost; 2009 Jan; 101(1):151-6. PubMed ID: 19132202
[TBL] [Abstract][Full Text] [Related]
11. [The clinico-functional characteristics of the reversal of coronary and myocardial failure in IHD patients after direct myocardial revascularization].
Cherniavskiĭ AM; Garganeeva AA; Tepliakov VM; Shipulin VM; Aptekar' VD
Ter Arkh; 1996; 68(4):36-40. PubMed ID: 9324786
[TBL] [Abstract][Full Text] [Related]
12. [Plasma fibrinogen during the acute stage of angina or myocardial infarct].
de la Llata-Romero M; Cancino C; Cuan V; López-Santibáñez J; Silvia Oropeza E; Ariza-Andraca H
Gac Med Mex; 1997; 133(3):175-80; discussion 181. PubMed ID: 9303865
[TBL] [Abstract][Full Text] [Related]
13. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial.
Fresco C; Maggioni AP; Signorini S; Merlini PA; Mocarelli P; Fabbri G; Lucci D; Tubaro M; Gattone M; Schweiger C;
Ital Heart J; 2002 Oct; 3(10):587-92. PubMed ID: 12478816
[TBL] [Abstract][Full Text] [Related]
14. [Two year follow-up of acute ischemic syndrome without ST elevation].
Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
[TBL] [Abstract][Full Text] [Related]
15. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
Okmen E; Cakmak M; Tartan Z; Cam N
Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
[TBL] [Abstract][Full Text] [Related]
16. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on value of severity of patient with coronary artery disease evaluated with the thrombosis in myocardial infarction risk score].
Zheng XY; Meng XK; Li WG; Yang J; Wei G; Fang R
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Apr; 16(4):239-41. PubMed ID: 15068722
[TBL] [Abstract][Full Text] [Related]
18. [Instruction of patients and a delay of treatment in myocardial infarction and unstable angina in the Krakow Program of Secondary Prevention of Ischaemic Heart Disease (IHD)].
Pajak A; Jankowski P; Dojka E; Kawecka-Jaszcz K
Przegl Lek; 2001; 58(10):903-7. PubMed ID: 11957816
[TBL] [Abstract][Full Text] [Related]
19. [Hemostasis disturbances in myocardial ischemia].
Habis M; Gonzalez C; Jacq L; Pezzano M; Schaison F; Lardoux H
Ann Cardiol Angeiol (Paris); 2000 Dec; 49(8):480-7. PubMed ID: 12555436
[TBL] [Abstract][Full Text] [Related]
20. [Role of the hemostasis in unstable angina pectoris].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
